These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 11474792)

  • 1. Ritonavir: an extraordinary example of conformational polymorphism.
    Bauer J; Spanton S; Henry R; Quick J; Dziki W; Porter W; Morris J
    Pharm Res; 2001 Jun; 18(6):859-66. PubMed ID: 11474792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular, Solid-State and Surface Structures of the Conformational Polymorphic Forms of Ritonavir in Relation to their Physicochemical Properties.
    Wang C; Rosbottom I; Turner TD; Laing S; Maloney AGP; Sheikh AY; Docherty R; Yin Q; Roberts KJ
    Pharm Res; 2021 Jun; 38(6):971-990. PubMed ID: 34009625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ritonavir Form III: A New Polymorph After 24 Years.
    Yao X; Henry RF; Zhang GGZ
    J Pharm Sci; 2023 Jan; 112(1):237-242. PubMed ID: 36195132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase transformation in conformational polymorphs of nimesulide.
    Sanphui P; Sarma B; Nangia A
    J Pharm Sci; 2011 Jun; 100(6):2287-99. PubMed ID: 21491446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PH-induced nanosegregation of ritonavir to lyotropic liquid crystal of higher solubility than crystalline polymorphs.
    Rodríguez-Spong B; Acciacca A; Fleisher D; Rodríguez-Hornedo N
    Mol Pharm; 2008; 5(6):956-67. PubMed ID: 19434919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization.
    Morissette SL; Soukasene S; Levinson D; Cima MJ; Almarsson O
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2180-4. PubMed ID: 12604798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a Weakly Acidic Amorphous Solid Dispersion of the Weak Base Ritonavir with Equivalent In Vitro and In Vivo Performance to Norvir Tablet.
    Ellenberger DJ; Miller DA; Kucera SU; Williams RO
    AAPS PharmSciTech; 2018 Jul; 19(5):1985-1997. PubMed ID: 29869311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures and physicochemical properties of amisulpride polymorphs.
    Zhang WP; Chen DY
    J Pharm Biomed Anal; 2017 Jun; 140():252-257. PubMed ID: 28371719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Solvent Selection on the Crystallizability and Polymorphic Selectivity Associated with the Formation of the "Disappeared" Form I Polymorph of Ritonavir.
    Wang C; Ma CY; Hong RS; Turner TD; Rosbottom I; Sheikh AY; Yin Q; Roberts KJ
    Mol Pharm; 2024 Jul; 21(7):3525-3539. PubMed ID: 38900600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of polymorphism and solvation in tranilast.
    Vogt FG; Cohen DE; Bowman JD; Spoors GP; Zuber GE; Trescher GA; Dell'orco PC; Katrincic LM; Debrosse CW; Curtis Haltiwanger R
    J Pharm Sci; 2005 Mar; 94(3):651-65. PubMed ID: 15666296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational Energy Landscape of the Ritonavir Molecule.
    Chakraborty D; Sengupta N; Wales DJ
    J Phys Chem B; 2016 May; 120(19):4331-40. PubMed ID: 27123749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions.
    Dhore PW; Dave VS; Saoji SD; Bobde YS; Mack C; Raut NA
    Pharm Dev Technol; 2017 Feb; 22(1):90-102. PubMed ID: 27291246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-state characterization of chlordiazepoxide polymorphs.
    Singh D; Marshall PV; Shields L; York P
    J Pharm Sci; 1998 May; 87(5):655-62. PubMed ID: 9572919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state form screen of cardiosulfa and its analogues.
    Kumar SS; Rana S; Nangia A
    Chem Asian J; 2013 Jul; 8(7):1551-68. PubMed ID: 23616361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.
    Martínez-Ohárriz MC; Martín C; Goñi MM; Rodríguez-Espinosa C; Tros de Ilarduya-Apaolaza MC; Sánchez M
    J Pharm Sci; 1994 Feb; 83(2):174-7. PubMed ID: 8169784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone Form V: A Late Appearing Thermodynamic Polymorph of a Pharmaceutical.
    Braun DE; Vickers M; Griesser UJ
    Mol Pharm; 2019 Jul; 16(7):3221-3236. PubMed ID: 31075201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization, spectral, crystallographical, and thermoanalytical studies of succinobucol polymorphism.
    Jurček O; Lahtinen M; Wimmer Z; Drašar P; Kolehmainen E
    J Pharm Sci; 2012 May; 101(5):1794-802. PubMed ID: 22323097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Old Polymorph, New Technique: Assessing Ritonavir Crystallinity Using Low-Frequency Raman Spectroscopy.
    Hatipoglu MK; Zaker Y; Willett DR; Gupta N; Rodriguez JD; Patankar S; Capella P; Yilmaz H
    Anal Chem; 2023 Oct; 95(41):15325-15332. PubMed ID: 37796650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubility and crystal nucleation in organic solvents of two polymorphs of curcumin.
    Liu J; Svärd M; Hippen P; Rasmuson ÅC
    J Pharm Sci; 2015 Jul; 104(7):2183-9. PubMed ID: 25950658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two polymorphs of lornoxicam.
    Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S
    J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.